ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Bioink Based on the DECM for 3D-Bioprinting of Bionic Pancreas – First Results of Animal

    M. Klak1, K. Kosowska1, T. Bryniarski1, I. Lojszczyk1, T. Dobrzanski2, G. Tymicki1, A. Filip1, A. A. Szczepankiewicz3, R. Olkowski4, A. Kosowska4, A. Berman1, A. Kaminski4, M. Wszola1

    1Foundation of Research and Science Development, Warsaw, Poland, 2Polbionica LTD, Warsaw, Poland, 3Institute of Experimental Biology M. Nencki PAN, Warsaw, Poland, 4Medical University of Warsaw, Warsaw, Poland

    *Purpose: Tissue engineering is an interdisciplinary field involving activities based on two interrelated areas: developing new methods to repair, regenerate and replace damaged tissues and…
  • 2022 American Transplant Congress

    Desensitization Using Costimulatory Blockade and Bortezomib to Prevent DSA Formation and Rejection in Reconstructive Transplantation

    B. Oh, F. Messner, Y. Guo, G. Brandacher

    Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Sensitization in form of donor-specific antibodies (DSA) and subsequent antibody-mediated rejection constitute some of the greatest risk factors for allograft rejection and long-term graft…
  • 2022 American Transplant Congress

    Post-Xenotransplant Antibody Specificities Against Swine, Monkey and Human Leukocyte Antigens in Highly Sensitized Nonhuman Primate Model

    I. DeLaura, I. Anwar, M. Manook, D. Olaso, J. Yoon, R. Baldi, A. Jackson, S. Knechtle, J. Kwun

    Surgery, Duke Transplant Center, Durham, NC

    *Purpose: Xenotransplantation has been proposed as a bridge to transplant for allosensitized patients. However, the potential of xenotransplantation to broaden HLA allosensitization due to MHC…
  • 2022 American Transplant Congress

    Gender Imbalance in Kidney Transplantation in Japan

    Y. Nakagawa1, M. Mieno2, H. Date3, H. Sasaki3, Y. Takada4, T. Ito3, Y. Tanaka3, S. Horie4, D. Ogasa4

    1Department of Urology, Juntendo University, Tokyo, Japan, 2Jichi Medical University, Tochigi, Japan, 3The Japan Society for Transplantation Gender Equality Committee, Tokyo, Japan, 4Department of Urology,, Juntendo University, Tokyo, Japan

    *Purpose: Japan has a chronic shortage of donors. Therefore, kidney transplantation between elderly couples has increased. We examined how differences in gender and donor age…
  • 2022 American Transplant Congress

    Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients

    W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han

    Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of

    *Purpose: The use of immunosuppressive agents, especially glucocorticoids, are associated with increased risks of bone loss in kidney transplant recipients (KTRs). Denosumab, a potent antiresorptive…
  • 2022 American Transplant Congress

    Risk Factors for Early Post Transplant Cardiac Dysfunction After Liver Transplantation

    V. Subramanian1, K. Bowers2, H. Kalagotla2, J. Buggs1, N. Kemmer1, K. Dhanireddy1

    1Transplant Institute, Tampa General Hospital, Tampa, FL, 2University of South Florida, Tampa, FL

    *Purpose: Cardiovascular complications after liver transplantation (LTx) are a leading cause of morbidity and mortality. The goal of this study was to evaluate risk factors…
  • 2022 American Transplant Congress

    Lucas Device Assisted Uncontrolled Dcd Kidney Transplantation – A Feasible but Underutilized Option in the United States

    S. Nagaraju, S. Vaishnav, R. Savilla, M. Moore, J. B. Africa

    Renal Transplant, Charleston Area Medical Center, Charleston, WV

    *Purpose: Uncontrolled DCD (uDCD) procurement involves either normo-thermic or hypothermic regional perfusion to reduce ischemic injury. We report a series of successful kidney transplant utilizing…
  • 2022 American Transplant Congress

    Sodium-Glucose Cotransporter 2 Inhibitors to Treat Diabetes Mellitus After Kidney Transplant

    H. M. Brokmeier1, S. B. Leung1, A. Kukla2, K. C. Mara3, P. Shah4, Y. Kudva4, G. K. Mour5, H. M. Wadei6, J. M. Hill7, M. D. Stegall8, A. Lemke1

    1Pharmacy, Mayo Clinic, Rochester, MN, 2Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, 5Nephrology Transplant, Mayo Clinic, Phoenix, AZ, 6Nephrology, Mayo Clinic, Jacksonville, FL, 7Transplant, Mayo Clinic, Rochester, MN, 8Division of Transplant Surgery, Mayo Clinic, Rochester, MN

    *Purpose: This study describes experience prescribing sodium-glucose cotransport 2 inhibitors (SGLT2i) after kidney transplant to evaluate safety and effectiveness.*Methods: This is a retrospective, institutional review…
  • 2022 American Transplant Congress

    Center Volume and Transplant Outcomes in Adult Kidney Transplant Recipients; A Competing Risk Analysis

    A. Azhar1, E. Defor1, L. Kamal1, D. Bandyopadhyay1, B. Tanriover2, G. Gupta1

    1Virginia Commonwealth University, Richmond, VA, 2University of Arizona, Tuscon, AZ

    *Purpose: The precise effect of center volume is a much-debated topic in the field of transplantation. Several studies have shown better post-transplant outcomes in higher…
  • 2022 American Transplant Congress

    Baseline Findings from the UREAACT Trial to Improve Medication Adherence in Youth with Kidney Transplants

    S. Amaral1, P. Kwong2, J. Zhu2, R. George3, N. Rodig4, B. Warady5, J. Smith6, A. Bobrowski7, D. Matossian8, N. Zelikovsky9, L. Schwartz1, P. Reese2, R. Goldfarb Terry1, J. Reason2, A. Chung1, S. Furth1

    1CHOP, Phila, PA, 2UPenn, Phila, PA, 3CHOA, Atlanta, GA, 4Boston Children's, Boston, MA, 5Children's Mercy, Kansas City, MO, 6Seattle Children's, Seattle, WA, 7Cleveland Clinic, Cleveland, OH, 8Lurie Children's, Chicago, IL, 9LaSalle Univ, Phila, PA

    *Purpose: This abstract describes the design and baseline characteristics of participants in the U-REAACT trial, a study to improve medication adherence in youth with kidney…
  • « Previous Page
  • 1
  • …
  • 177
  • 178
  • 179
  • 180
  • 181
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences